Lupin (LUPIN) — Board Meeting

Lupin Limited's board approved unaudited Q3 FY2026 results (ended December 31, 2025) with consolidated revenue of ₹71,675.2 million and net profit of ₹11,105.1 million. Nine-month consolidated net profit reached ₹38,461.2 million. Exceptional charges of ₹4,265.7 million included antitrust litigation provisions (₹4,493.9 million) and Mirabegron settlement (₹1,348.1 million). The company acquired Renascience Pharma Limited and awaits regulatory approval for VISUfarma B.V. acquisition (EUR 190 million). Auditors completed limited review with no material misstatements.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this board meeting affect Lupin Limited's outlook?" "What did Lupin Limited announce on 12 February 2026?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 12 February 2026

COALINDIA Coal India Limited Corporate Action COALINDIA Coal India Limited Corporate Action BAJFINANCE Bajaj Finance Limited Corporate Action TATASTEEL Tata Steel Limited Financial Results APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results DIVISLAB Divi's Laboratories Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.